Harbor動態大型股核心主動型ETF INFO 深 滬
已收盤 11-06 16:00:00 美东时间
26.8482
+0.098
+0.37%
華盛通- 最 高27.07
- 今 開26.93
- 成交量 3.68万股
- 最 低 26.8482
- 昨 收 26.75
- 總市值 91.42万
- 52周最高 28.88
- 市盈率 靜 8.93
- 換手率 107.93%
- 52周最低 22.7099
- 委 比 0.00%
- 總股本 3.41万
- 歷史最高 28.88
- 量 比 0.54
- 振 幅 0.83%
- 歷史最低 17.0641
- 每 手 1
- 風險率 1.70%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多3i Infotech Releases Q2 and H1 FY27 Earnings Call Transcript
The latest announcement is out from 3i Infotech Limited ( ($IN:3IINFOLTD) ). 3i...
11-07 03:12
European Commission approves AkzoNobel and Axalta merger of equals
AkzoNobel and Axalta received conditional EU approval for their all-stock merger, creating a global coatings leader with $17B revenue. The deal, expected to close in early 2027, includes AkzoNobel divesting its European vehicle refinish business to address competition concerns. The merger combines complementary portfolios, technologies, and brands, with both CEOs expressing confidence in accelerating growth and innovation.
11-06 16:45
McEwen Exercises Inventus Warrants and Increases Ownership to 12.7%
McEwen Inc. announced that it acquired 9.2 million common shares of Inventus Mining Corporation by exercising warrants at CAD$0.12 per share, totaling CAD$1.104 million. This purchase increased McEwen's ownership from 20 million shares (9%) to 29.2 million shares (12.7%). The acquisition was made for investment purposes, and McEwen reserves the right to buy or sell additional securities of Inventus based on market conditions. McEwen is a mining c...
11-05 16:44
Lantheus Welcomes CMS CY27 Final Rule Advancing Access to Diagnostic Radiopharmaceuticals
Lantheus Holdings welcomed CMS's final rule maintaining separate payment for advanced diagnostic imaging agents and confirming PYLARIFY TruVu's Transitional Pass-Through status through September 30, 2029. A permanent HCPCS code (A9613) for PYLARIFY TruVu became effective October 1, 2026, aiding billing and reimbursement. Amanda Morgan highlighted the rule's support for patient access to advanced imaging and innovative radiopharmaceuticals, emphas...
11-05 12:15
Solid Biosciences Reports Third Quarter 2026 Financial Results and Provides Business Updates
Solid Biosciences reported positive progress in its Duchenne muscular dystrophy (SGT-003) and Friedreich’s ataxia (SGT-212) programs, with both treatments well-tolerated in clinical trials. The company secured $348.9 million in cash and expects to fund operations into H1 2028. Q3 2026 saw a net loss of $53.9 million, with increased R&D and G&A expenses. Solid plans a Type C FDA meeting for SGT-003 in late Q4 2026 and anticipates initial SGT-212 d...
11-04 21:07
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Medicus Pharma Ltd. subsidiary SkinJect, Inc. has entered into a non-binding letter of intent with a SPAC for a proposed $135 million business combination to establish a dedicated platform for its rare-disease dermatology program in Gorlin syndrome. The transaction would allow Medicus to retain majority ownership while securing financing for the SKNJCT-005 NDA-enabling study. SkinJect’s investigational microneedle patch delivers doxorubicin for b...
11-04 13:30
Teva and Samsung Bioepis Announce Agreement to Commercialize Two FDA-Approved Biosimilars in the U.S.
Teva Pharmaceutical Industries Ltd. has entered into a license and commercialization agreement with Samsung Bioepis Co., Ltd. for two FDA-approved immunology biosimilars: infliximab-abda and ETICOVO® (etanercept-ykro). Under the agreement, Teva will obtain U.S. commercialization rights for etanercept-ykro at closing and for infliximab-abda in Q3 2027. The collaboration combines Samsung Bioepis’ biosimilar expertise with Teva’s commercial capabili...
11-03 10:00
Corporate Action Payments Processed for Multiple Securities
An update from INFO YATIRIM MENKUL DEGERLER A.S ( ($TR:INFO) ) is now available...
11-02 22:54
McEwen Q3 2026 Results Conference Call
McEwen Inc. (NYSE/TSX: MUX) invites investors to join its Q3 2026 conference call on November 10, 2026, at 11:00 a.m. EST. Management will discuss financial results and project developments, followed by a Q&A session. The call can be accessed via webcast or phone, with registration links provided. McEwen, a mining company, focuses on gold, silver, and copper production, with a major copper project in Argentina. The company emphasizes shareholder ...
11-02 18:33
Magna to Host Investor Day on November 11, 2026
Magna International Inc. will host its 2026 Investor Day on November 11, 2026, in New York City. Key executives, including President and CEO Swamy Kotagiri and CFO Philip Fracassa, will present. The event will include a live webcast accessible via registration on www.magna.com/investorday2026-virtual. A replay and materials will be available post-event. Magna is a leading global automotive supplier with operations in 27 countries.
11-02 13:00
